Finance

Lists
ERMA:STO
Enorama Pharma AB
SEK 0.71
+0.86%
(+0.0060) 1D
Sep 4, 5:00:00 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ERMA...
Open
SEK 0.70
High
SEK 0.71
Low
SEK 0.70
Mkt. cap
52.66M
Avg. vol.
332.23K
Volume
16.26K
52-wk high
SEK 3.00
52-wk low
SEK 0.21
EPS
-SEK 0.80
Shares outstanding
74.59M
No. of employees
4
Open
SEK 0.70
High
SEK 0.71
Low
SEK 0.70
Mkt. cap
52.66M
Avg. vol.
332.23K
Volume
16.26K
52-wk high
SEK 3.00
52-wk low
SEK 0.21
EPS
-SEK 0.80
Shares outstanding
74.59M
No. of employees
4
About Enorama Pharma AB
CEOMats Rönngard
Employees4
Founded2006
Headquarters-
SectorPharmaceutical industry
Websiteenorama.se
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-193.00K
1.75M
-108.00K
136.00K
Cost of goods sold
1.07M
5.28M
-58.00K
-
Cost of revenue
1.07M
5.28M
-58.00K
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.91M
14.68M
11.99M
11.62M
Operating expense
11.07M
14.24M
12.51M
11.84M
Total operating expenses
12.15M
19.52M
12.45M
11.84M
Operating income
-12.34M
-17.77M
-12.56M
-11.71M
Other non operating income
-
-8.00K
1.68M
1.00K
EBT including unusual items
-13.35M
-20.57M
-12.64M
-13.12M
EBT excluding unusual items
-13.35M
-20.57M
-12.64M
-13.12M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
78.00K
-539.00K
424.00K
131.00K
Net income
-13.35M
-20.57M
-12.64M
-13.12M
Net profit margin
6,915.03%
-1,175.66%
11,708.33%
-9,643.38%
Earnings per share
-
-
-
-
Interest and investment income
-
9.08M
1.51M
630.00K
Interest expense
-1.01M
-
-3.28M
-2.04M
Net interest expenses
-1.01M
9.08M
-1.77M
-1.41M
Depreciation and amortization charges
89.00K
92.00K
90.00K
90.00K
EBITDA
-12.34M
-17.68M
-12.47M
-11.62M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps